Literature DB >> 20969965

Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues.

Phoebe G Spetsieris1, David Eidelberg.   

Abstract

Consistent functional brain abnormalities in Parkinson's disease (PD) are difficult to pinpoint because differences from the normal state are often subtle. In this regard, the application of multivariate methods of analysis has been successful but not devoid of misinterpretation and controversy. The Scaled Subprofile Model (SSM), a principal components analysis (PCA)-based spatial covariance method, has yielded critical information regarding the characteristic abnormalities of functional brain organization that underlie PD and other neurodegenerative disorders. However, the relevance of disease-related spatial covariance patterns (metabolic brain networks) and the most effective methods for their derivation has been a subject of debate. We address these issues here and discuss the inherent advantages of proper application as well as the effects of the misapplication of this methodology. We show that ratio pre-normalization using the mean global metabolic rate (GMR) or regional values from a "reference" brain region (e.g. cerebellum) that may be required in univariate analytical approaches is obviated in SSM. We discuss deviations of the methodology that may yield erroneous or confounding factors.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20969965      PMCID: PMC3020239          DOI: 10.1016/j.neuroimage.2010.10.025

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  35 in total

Review 1.  Statistical limitations in functional neuroimaging. I. Non-inferential methods and statistical models.

Authors:  K M Petersson; T E Nichols; J B Poline; A P Holmes
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-07-29       Impact factor: 6.237

2.  Reproducibility of regional metabolic covariance patterns: comparison of four populations.

Authors:  J R Moeller; T Nakamura; M J Mentis; V Dhawan; P Spetsieres; A Antonini; J Missimer; K L Leenders; D Eidelberg
Journal:  J Nucl Med       Date:  1999-08       Impact factor: 10.057

3.  Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.

Authors:  Andrew Feigin; Angelo Antonini; Masafumi Fukuda; Roberta De Notaris; Riccardo Benti; Gianni Pezzoli; Marc J Mentis; James R Moeller; David Eidelberg
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

4.  Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.

Authors:  Yilong Ma; Chengke Tang; Phoebe G Spetsieris; Vijay Dhawan; David Eidelberg
Journal:  J Cereb Blood Flow Metab       Date:  2006-06-28       Impact factor: 6.200

5.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

Review 6.  The diagnosis of Parkinson's disease.

Authors:  Eduardo Tolosa; Gregor Wenning; Werner Poewe
Journal:  Lancet Neurol       Date:  2006-01       Impact factor: 44.182

7.  FDG PET in the differential diagnosis of parkinsonian disorders.

Authors:  Thomas Eckert; Anna Barnes; Vijay Dhawan; Steve Frucht; Mark F Gordon; Andrew S Feigin; D Eidelberg
Journal:  Neuroimage       Date:  2005-04-26       Impact factor: 6.556

8.  The metabolic pathology of dopa-responsive dystonia.

Authors:  Kotaro Asanuma; Yilong Ma; Chaorui Huang; Maren Carbon-Correll; Christine Edwards; Deborah Raymond; Susan B Bressman; James R Moeller; David Eidelberg
Journal:  Ann Neurol       Date:  2005-04       Impact factor: 10.422

9.  Quantification of Parkinson's disease-related network expression with ECD SPECT.

Authors:  Thomas Eckert; Koen Van Laere; Chengke Tang; Daniel E Lewis; Christine Edwards; Patrick Santens; David Eidelberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-10       Impact factor: 9.236

10.  Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease.

Authors:  Maja Trost; Sherwin Su; Philip Su; Ruoh-Fang Yen; Ham-Min Tseng; Anna Barnes; Yilong Ma; David Eidelberg
Journal:  Neuroimage       Date:  2006-02-08       Impact factor: 6.556

View more
  68 in total

1.  Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism.

Authors:  Yilong Ma; Shichun Peng; Phoebe G Spetsieris; Vesna Sossi; David Eidelberg; Doris J Doudet
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-30       Impact factor: 6.200

Review 2.  Brain networks in Huntington disease.

Authors:  David Eidelberg; D James Surmeier
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

3.  Network Structure and Function in Parkinson's Disease.

Authors:  Ji Hyun Ko; Phoebe G Spetsieris; David Eidelberg
Journal:  Cereb Cortex       Date:  2018-12-01       Impact factor: 5.357

4.  Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment.

Authors:  Meggan Mackay; An Vo; Chris C Tang; Michael Small; Erik W Anderson; Elisabeth J Ploran; Justin Storbeck; Brittany Bascetta; Simran Kang; Cynthia Aranow; Carl Sartori; Philip Watson; Bruce T Volpe; Betty Diamond; David Eidelberg
Journal:  JCI Insight       Date:  2019-01-10

5.  Abnormal metabolic network activity in REM sleep behavior disorder.

Authors:  Florian Holtbernd; Jean-François Gagnon; Ron B Postuma; Yilong Ma; Chris C Tang; Andrew Feigin; Vijay Dhawan; Mélanie Vendette; Jean-Paul Soucy; David Eidelberg; Jacques Montplaisir
Journal:  Neurology       Date:  2014-01-22       Impact factor: 9.910

6.  Parkinson's disease-related spatial covariance pattern identified with resting-state functional MRI.

Authors:  Tao Wu; Yilong Ma; Zheng Zheng; Shichun Peng; Xiaoli Wu; David Eidelberg; Piu Chan
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-03       Impact factor: 6.200

7.  Functional impact of subthalamotomy by magnetic resonance-guided focused ultrasound in Parkinson's disease: a hybrid PET/MR study of resting-state brain metabolism.

Authors:  Rafael Rodriguez-Rojas; Jose A Pineda-Pardo; Raul Martinez-Fernandez; Rosalie V Kogan; Carlos A Sanchez-Catasus; Marta Del Alamo; Frida Hernández; Lina García-Cañamaque; Klaus L Leenders; Jose A Obeso
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-08       Impact factor: 9.236

8.  Dopaminergic correlates of metabolic network activity in Parkinson's disease.

Authors:  Florian Holtbernd; Yilong Ma; Shichun Peng; Frank Schwartz; Lars Timmermann; Lutz Kracht; Gereon R Fink; Chris C Tang; David Eidelberg; Carsten Eggers
Journal:  Hum Brain Mapp       Date:  2015-06-03       Impact factor: 5.038

9.  Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia.

Authors:  Vincent A Jourdain; Chris C Tang; Florian Holtbernd; Christian Dresel; Yoon Young Choi; Yilong Ma; Vijay Dhawan; David Eidelberg
Journal:  JCI Insight       Date:  2016-09-22

10.  Regional covariance patterns of gray matter alterations in Alzheimer's disease and its replicability evaluation.

Authors:  Xiaojuan Guo; Kewei Chen; Yumei Zhang; Yan Wang; Li Yao
Journal:  J Magn Reson Imaging       Date:  2013-04-15       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.